The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.
Br J Dermatol
; 185(5): 935-944, 2021 11.
Article
em En
| MEDLINE
| ID: mdl-33829482
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psoríase
/
Espondilite Anquilosante
/
Artrite Psoriásica
/
Neoplasias
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article